PAREXEL
LeaveRussia detail: Scaling Back
PAREXEL International is a global provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today.
Business in Russia
PAREXEL have 6,000+ staff, with 30+ offices across the region, early phase clinics located in Berlin and London, and clinical trial supplies and logistics depots located in Germany and Russia.
Decision trail
Decision date 25/08/2022 · Reference ↗
Received revenues in Russia in 2021-2024, there is no any official announcement. Revenue decreased in 2024 vs 2023 by more than -20%.
Local stats (LeaveRussia)
Status history since 2022
- 03/08/2026 — scaling back · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional